Proportion of second cancers attributable to radiotherapy treatment in adults: A cohort study in the US SEER cancer registries

The Lancet Oncology

Volumn 12, Issue 4, 2011, Pages 353-360

  De Gonzalez, Amy Berrington ^a   Curtis, Rochelle E ^a   Kry, Stephen F ^b   Gilbert, Ethel ^a   Lamart, Stephanie ^a   Berg, Christine D ^a   Stovall, Marilyn ^b   Ron, Elaine ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANUS CANCER; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURVIVOR; COHORT ANALYSIS; CONTROLLED STUDY; ENDOMETRIUM CANCER; EYE CANCER; FOLLOW UP; HUMAN; LARYNX CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MOUTH CANCER; ORBIT CANCER; PHARYNX CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION INDUCED NEOPLASM; RECTUM CANCER; RISK FACTOR; SALIVARY GLAND CANCER; SECOND CANCER; SOFT TISSUE CANCER; SURVIVAL RATE; SURVIVAL TIME; TESTIS CANCER; THYROID CANCER; UTERINE CERVIX CANCER;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; REGISTRIES; RISK; SEER PROGRAM;

EID: 79953184609     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70061-4     Document Type: Article

References (37)

1. Lawrence TS, Haken RK Ten, Giaccia A Principles of radiation oncology. Cancer: principles and practice of oncology 2008, Lippincott Williams and Wilkins, Philadelphia. 8th edn. V.T. DeVita, T.S. Lawrence, S.A. Rosenberg (Eds.).
2. Fraumeni JF, Curtis RE, Edwards BK, Tucker MA Introduction. New malignancies among cancer survivors: SEER cancer registries, 1973-2000 2006, 1-7. National Cancer Institute, Bethesda, MD. R.E. Curtis, D.M. Freedman, E. Ron (Eds.).
3. de Gonzalez A Berrington, Curtis R, Gilbert E, et al. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer 2010, 102:220-226.
4. Lönn S, Gilbert ES, Ron E, Smith SA, Stovall M, Curtis RE Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer. Cancer Epidemiol Biomarkers Prev 2010, 9:464-474.
5. Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007, 168:1-64.
6. Stovall M, Weathers R, Kasper C, et al. Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies. Radiat Res 2006, 166:141-157.
7. Edmonds CJ, Smith T The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 1986, 59:45-51.
8. Remy H, Borget I, Leboulleux S, et al. 131I effective half-life and dosimetry in thyroid cancer patients. J Nucl Med 2008, 49:1445-1450.
9. Kolbert KS, Pentlow KS, Pearson JR, et al. Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software. J Nucl Med 2007, 48:143-149.
10. Curtis RE, Ries LAG Methods. New malignancies among cancer survivors: SEER cancer registries, 1973-2000 2006, 9-14. National Cancer Institute, Bethesda, MD. R.E. Curtis, D.M. Freedman, E. Ron (Eds.).
11. Yasui Y, Liu Y, Neglia JP, et al. A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. Am J Epidemiol 2003, 15:1108-1113.
12. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106.
13. Boice JD, Day NE, Andersen A, et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 1985, 74:955-975.
14. Brenner DJ, Curtis RE, Hall EJ, Ron E Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000, 8:398-406.
15. Boice JD, Engholm G, Kleinerman RA, et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 1988, 116:3-55.
16. Inskip PD, Stovall M, Flannery JT Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst 1994, 86:983-988.
17. Stovall M, Smith SA, Langholz BM, et al. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys 2008, 72:1021-1030.
18. Boice JD, Harvey EB, Blettner M, Stovall M, Flannery JT Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 1992, 326:781-785.
19. Rubino C, de Vathaire F, Shamsaldin A, Labbe M, Lê MG Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer 2003, 89:840-846.
20. Rubino C, Shamsaldin A, Lê MG, et al. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment. Breast Cancer Res Treat 2005, 89:277-288.
21. van den Belt-Dusebout AW, Aleman BM, Besseling G, et al. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. Int J Radiat Oncol Biol Phys 2009, 75:1420-1429.
22. Hashibe M, Ritz B, Le AD, Li G, Sankaranarayanan R, Zhang ZF Radiotherapy for oral cancer as a risk factor for second primary cancers. Cancer Lett 2005, 220:185-195.
23. Warnakulasuriya KA, Robinson D, Evans H Multiple primary tumours following head and neck cancer in southern England during 1961-98. J Oral Pathol Med 2003, 32:443-449.
24. Birgisson H, Påhlman L, Gunnarsson U, Glimelius B Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 2005, 23:6126-6131.
25. Kendal WS, Nicholas G A population-based analysis of second primary cancers after irradiation for rectal cancer. Am J Clin Oncol 2007, 30:333-339.
26. Gao X, Fisher SG, Mohideen N, Emami B Second primary cancers in patients with laryngeal cancer: a population-based study. Int J Radiat Oncol Biol Phys 2003, 56:427-435.
27. Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Lê MG Increased risk of second cancers following breast cancer: role of the initial treatment. Breast Cancer Res Treat 2000, 61:183-195.
28. Levi F, Randimbison L, Te VC, La Vecchia C Cancer risk after radiotherapy for breast cancer. Br J Cancer 2006, 95:390-392.
29. Schaapveld M, Visser O, Louwman MJ, et al. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. J Clin Oncol 2008, 26:1239-1246.
30. Andersson M, Jensen MB, Engholm G, Storm H Henrik Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001. Acta Oncol 2008, 47:755-764.
31. Chaturvedi AK, Engels EA, Gilbert ES, et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst 2007, 99:1634-1643.
32. Abdel-Wahab M, Reis IM, Hamilton K Second primary cancer after radiotherapy for prostate cancer-a seer analysis of brachytherapy versus external beam radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72:58-68.
33. Travis LB, Fosså SD, Schonfeld SJ, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 2005, 97:1354-1365.
34. Rubino C, de Vathaire F, Dottorini ME, et al. Second primary malignancies in thyroid cancer patients. Br J Cancer 2003, 89:1638-1644.
35. Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 2008, 93:504-515.
36. IARC monographs on the evaluation of carcinogenic risks to humans-volume 83: tobacco smoke and involuntary smoking 2004, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, Lyon.
37. Hall EJ Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006, 65:1-7.